Diabetic Retinopathy and Diabetic Macular Edema - Screening.

Q4 Medicine

Ceska a Slovenska Oftalmologie Pub Date : 2023-01-01 DOI:10.31348/2023/29

J Němčanský, J Studnička, D Vysloužilová, J Ernest, P Němec

{"title":"Diabetic Retinopathy and Diabetic Macular Edema - Screening.","authors":"J Němčanský, J Studnička, D Vysloužilová, J Ernest, P Němec","doi":"10.31348/2023/29","DOIUrl":null,"url":null,"abstract":"<p><p>Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of severe visual loss in the working population. Therefore, both DR and DME have a significant socioeconomic and health impact, which taking into account the epidemiologic predictions is expected to increase. A crucial role in the management of DR and DME (not only for individuals, but also for the population) is played by an adequate screening program. This is based on the structure and organization of the healthcare system, the latest scientific developments in diagnostics (imaging) as well as technological advancements in computing (artificial intelligence, telemedicine) and their practical use. The recommendation presented by World Health Organization is also important. This paper evaluates all these factors, including evidence-based medicine reports and experience from existing DR and DME screening programs in comparable countries. Based on an evaluation of these parameters, recommended guidelines have been formulated for screening for DR and DME in the Czech Republic, including linkage to the Czech National Screening Center and the organization of the healthcare system.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"79 5","pages":"250-255"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ceska a Slovenska Oftalmologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31348/2023/29","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Diabetic retinopathy (DR) and diabetic macular edema (DME) are leading causes of severe visual loss in the working population. Therefore, both DR and DME have a significant socioeconomic and health impact, which taking into account the epidemiologic predictions is expected to increase. A crucial role in the management of DR and DME (not only for individuals, but also for the population) is played by an adequate screening program. This is based on the structure and organization of the healthcare system, the latest scientific developments in diagnostics (imaging) as well as technological advancements in computing (artificial intelligence, telemedicine) and their practical use. The recommendation presented by World Health Organization is also important. This paper evaluates all these factors, including evidence-based medicine reports and experience from existing DR and DME screening programs in comparable countries. Based on an evaluation of these parameters, recommended guidelines have been formulated for screening for DR and DME in the Czech Republic, including linkage to the Czech National Screening Center and the organization of the healthcare system.

查看原文本刊更多论文

糖尿病视网膜病变和糖尿病黄斑水肿-筛选。

糖尿病性视网膜病变(DR)和糖尿病性黄斑水肿(DME)是导致工作人群严重视力丧失的主要原因。因此，DR和DME都具有重大的社会经济和健康影响，考虑到流行病学预测，这种影响预计会增加。在DR和DME的管理中(不仅对个人，而且对整个群体)，一个适当的筛查程序发挥着至关重要的作用。这是基于医疗保健系统的结构和组织，诊断(成像)的最新科学发展以及计算(人工智能，远程医疗)的技术进步及其实际应用。世界卫生组织提出的建议也很重要。本文评估了所有这些因素，包括循证医学报告和来自可比国家现有DR和DME筛查项目的经验。根据对这些参数的评估，已制定了捷克共和国DR和二甲醚筛查的推荐指南，包括与捷克国家筛查中心和卫生保健系统组织的联系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ceska a Slovenska Oftalmologie Medicine-Ophthalmology

CiteScore

0.80

自引率

0.00%

发文量

期刊介绍： - Redakce přijímá pouze práce vyhovující po odborné stránce, které jsou na odpovídající profesionální a formální úrovni. - Uveřejněná práce se stává majetkem časopisu, přetisknout její část nebo obrázek lze jen s citací původu. - Rukopis zasílejte v originále a dobře čitelné kopii (je nutná také kopie tabulek, legend, podle možnosti i obrázků). - Listy číslujte v pravém horním rohu a spojujte svorkou, nesešívejte. Přijímáme práce psané na jedné straně kvalitního bílého nelesklého papíru formátu A4 (neprůklepový) na psacím stroji nebo počítači s obvyklými typy.